Stock Watch 12/29/06

Another day of watching fails:
HRAY SIRI AVNR LMRA GHDX SYNM IVN ACTC

And also CLWT.

My curiosity for the day is Texas biotechnology company, Encysive Pharmaceuticals, ENCY, whose stock has tanked 24% on word that the FDA has now "classified its drug candidate Thelin as a Class II drug, which could complicate its approval process". The drug is already approved in Europe and "it has proved to be much safer than some existing treatments for pulmonary arterial hypertension, or high blood pressure".

And our forceswing candidate today is EPIX.